John Paulson Says He'll Dump Stocks If Kamala Harris Wins - Except for This Company
Madrigal Pharmaceuticals Insider Sold Shares Worth $1,551,490, According to a Recent SEC Filing
Madrigal Pharmaceuticals, Inc. to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
These Are the Stocks With the Largest Changes in Short Interest in July - GS
Is Madrigal Pharmaceuticals Stock a Buy?
Paulson & Co. Boosts Madrigal Pharma, Exits Alibbaba, Others in Q2
10 Health Care Stocks With Whale Alerts In Today's Session
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
When Will Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Breakeven?
Citigroup Maintains Buy on Madrigal Pharmaceuticals, Lowers Price Target to $371
Analysts Offer Insights on Healthcare Companies: Aytu BioScience (AYTU), Madrigal Pharmaceuticals (MDGL) and Third Harmonic Bio, Inc. (THRD)
Buy Rating Affirmed for Madrigal Pharmaceuticals on Strong Rezdiffra Sales and Promising Growth Outlook
Madrigal Pharmaceuticals Is Maintained at Outperform by Evercore ISI Group
Madrigal Pharmaceuticals Analyst Ratings
B. Riley Adjusts Price Target on Madrigal Pharmaceuticals to $194 From $200, Maintains Neutral Rating
Underperform Rating on Madrigal Pharmaceuticals Amid Rezdiffra's Commercial and Competitive Challenges
Express News | Madrigal Pharmaceuticals Inc : Evercore ISI Cuts Target Price to $360 From $405
Madrigal Pharmaceuticals Outperforms With Strong Q2 Revenue and Expanding Market Coverage
Madrigal Pharmaceuticals: Weighing Rezdiffra's Market Potential Against Uncertainties
Madrigal Pharmaceuticals, Inc. (MDGL) Q2 2024 Earnings Call Transcript